Alembic Pharma has a great run on the stock exchange with a 181% YOY return. However, given its’ high ROE, size of opportunity and reasonable valuations, there is still a lot of scope for gain in the stock says Meeta Shetty, CFA of HDFC Securities
Alembic Pharma has a great run on the stock exchange with a 181% YOY return. However, given its’ high ROE, size of opportunity and reasonable valuations, there is still a lot of scope for gain in the stock says Meeta Shetty, CFA, of HDFC Securities
Alembic Pharma is “Gearing for a leap” says Meeta Shetty of HDFC Securities in her initiating coverage report. Meeta Shetty has given convincing reasons that in view of the high CAGR of revenue, high ROE/ROCE of 40% +, the consistent free cash flows and high margin product opportunities, there is still great opportunity for gain in Alembic Pharma.
I want buy alembice fharma. Its right price. I want hold 10 years
It has really run up and after this report, it will go up even further, in the immediate short run. Is it worth the risk?
I have added a decent quantity, inspite of my caution above. So far, it had looked good and I made use (to enter) of 1 day when it crashed 6%